慢性肺炎患者的呼吸道肌肉强度和死亡率:系统性审查和元分析
Hiroki Mizusawa1, Kazuki Okura2, Masashi Shiraishi1
1Department of Rehabilitation, Kindai University Hospital, Minami-ku Sakai, Osaka Prefecture, Japan.
慢性阻塞性肺病 (COPD) 患者的最大吸气强度 (MIP) 与生存有关. 标准化MIP测试和选峰值启发性流量 (PIFR) 可以帮助风险分层和处理.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床流行病学 临床流行病学
背景情况:
- 呼吸道肌肉衰弱在COPD中很普遍,可能会影响预后.
- 目前对呼吸道肌肉强度的临床测试缺乏标准化,其对生存的预后价值尚不清楚.
研究的目的:
- 评估COPD患者的呼吸肌强度和生存率之间的关联.
- 总结其他实施指数的证据.
主要方法:
- 在PubMed/MEDLINE,CENTRAL和Web of Science (1990-2025) 的系统文献搜索.
- 包括观察队列和基线预后分析在报告所有原因死亡率的COPD患者中.
- 在适用的情况下,使用随机效应模型对时间到事件估计的元分析.
主要成果:
- 较低的吸入力与较高的死亡率相关 (汇总HR 0.97,95%CI 0.95-0.99).
- 特定的切断值 (MIP ≤55 cmH2O,MEP ≤80 cmH2O) 与严格限制的队列中较高的死亡率有关.
- 峰值吸气流量 (PIFR) <60 L/min与恶化和再接收有关;MEP和鼻鼻吸气压显示出不一致的预后信号.
结论:
- 最大吸气强度 (MIP) 显示了与COPD患者的存活率的一致关联.
- 为风险分层和指导吸入器选择,建议使用标准化的MIP测量协议和PIFR查.
更多相关视频
09:37Evaluation of Respiratory Muscle Activation Using Respiratory Motor Control Assessment RMCA in Individuals with Chronic Spinal Cord Injury
Published on: July 19, 2013
09:44Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
Published on: April 12, 2011
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
